172 related articles for article (PubMed ID: 16959246)
41. A novel subtelomeric translocation t(5;9) and a deletion of the RB1 gene in a patient with acute myeloid leukemia (AML-M0).
Lee J; Lu X; Shin ES; Kern WF; Mulvihill JJ; Li S
Cancer Genet Cytogenet; 2008 Feb; 181(1):36-9. PubMed ID: 18262051
[TBL] [Abstract][Full Text] [Related]
42. Chronic myelomonocytic leukemia with der(9)t(1;9)(q11;q34) as a sole abnormality.
Suh B; Park TS; Kim JS; Song J; Kim J; Yoo JH; Choi JR
Ann Clin Lab Sci; 2009; 39(3):307-12. PubMed ID: 19667417
[TBL] [Abstract][Full Text] [Related]
43. Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes.
Dargent JL; Mathieux V; Vidrequin S; Deghorain X; Vannuffel P; Rack K
Eur J Haematol; 2011 Jan; 86(1):87-90. PubMed ID: 21070368
[No Abstract] [Full Text] [Related]
44. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
[TBL] [Abstract][Full Text] [Related]
45. Infertility in a man with oligoasthenoteratozoospermia associated with nonrobertsonian translocation t(9;15)(p10;q10).
Aydos SE; Tükün A
Fertil Steril; 2006 Oct; 86(4):1001.e7-9. PubMed ID: 17027368
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a de novo balanced translocation in a patient with moderate mental retardation and dysmorphic features.
Haddad MR; Mignon-Ravix C; Cacciagli P; Mégarbané A; Villard L
Eur J Med Genet; 2009; 52(4):211-7. PubMed ID: 19379847
[TBL] [Abstract][Full Text] [Related]
47. A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature.
Levavi H; Tripodi J; Marcellino B; Mascarenhas J; Jones AV; Cross NCP; Gruenstein D; Najfeld V
Acta Haematol; 2019; 142(2):105-112. PubMed ID: 31063994
[TBL] [Abstract][Full Text] [Related]
48. Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis.
Gargallo P; Hagemeijer A; Vassallu P; Kornblihtt L; Heller P; Molinas F; Larripa I
Cancer Genet Cytogenet; 2004 Oct; 154(1):72-6. PubMed ID: 15381377
[TBL] [Abstract][Full Text] [Related]
49. An exceptional complex chromosomal rearrangement (CCR) with eight breakpoints involving four chromosomes (1;3;9;14) in an azoospermic male with normal phenotype.
Bartels I; Starke H; Argyriou L; Sauter SM; Zoll B; Liehr T
Eur J Med Genet; 2007; 50(2):133-8. PubMed ID: 17174164
[TBL] [Abstract][Full Text] [Related]
50. Advances in the therapy of chronic idiopathic myelofibrosis.
Arana-Yi C; Quintás-Cardama A; Giles F; Thomas D; Carrasco-Yalan A; Cortes J; Kantarjian H; Verstovsek S
Oncologist; 2006 Sep; 11(8):929-43. PubMed ID: 16951397
[TBL] [Abstract][Full Text] [Related]
51. Reciprocal translocation t(7;16)(q21.2;p13.3) in an infertile man.
Mikelsaar R; Pauklin M; Lissitsina J; Punab M
Fertil Steril; 2006 Sep; 86(3):719.e9-11. PubMed ID: 16952514
[TBL] [Abstract][Full Text] [Related]
52. Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.
O'Reilly J; Crawford J; Uzaraga J; Cannell P
Cancer Genet Cytogenet; 2005 Apr; 158(1):81-3. PubMed ID: 15771910
[TBL] [Abstract][Full Text] [Related]
53. Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders.
Rege-Cambrin G; Speleman F; Kerim S; Scaravaglio P; Carozzi F; Dal Cin P; Michaux JL; Offner F; Saglio G; Van den Berghe H
Leukemia; 1991 Dec; 5(12):1059-63. PubMed ID: 1774954
[TBL] [Abstract][Full Text] [Related]
54. Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation.
Steckel NK; Koldehoff M; Ditschkowski M; Beelen DW; Elmaagacli AH
Transplantation; 2007 Jun; 83(11):1518-20. PubMed ID: 17565328
[TBL] [Abstract][Full Text] [Related]
55. Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas.
Leich E; Haralambieva E; Zettl A; Chott A; Rüdiger T; Höller S; Müller-Hermelink HK; Ott G; Rosenwald A
J Pathol; 2007 Sep; 213(1):99-105. PubMed ID: 17582237
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation.
Guastadisegni MC; Lonoce A; Impera L; Albano F; D'Addabbo P; Caruso S; Vasta I; Panagopoulos I; Leszl A; Basso G; Rocchi M; Storlazzi CT
Mol Cancer; 2008 Oct; 7():80. PubMed ID: 18947387
[TBL] [Abstract][Full Text] [Related]
57. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.
Maire G; Brown CW; Bayani J; Pereira C; Gravel DH; Bell JC; Zielenska M; Squire JA
Cancer Genet Cytogenet; 2008 Mar; 181(2):81-92. PubMed ID: 18295659
[TBL] [Abstract][Full Text] [Related]
58. Renal metanephric adenoma with previously unreported cytogenetic abnormalities: case report and review of the literature.
Rakheja D; Lian F; Tomlinson GE; Ewalt DH; Schultz RA; Margraf LR
Pediatr Dev Pathol; 2005; 8(2):218-23. PubMed ID: 15747102
[TBL] [Abstract][Full Text] [Related]
59. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.
Toubai T; Tanaka J; Higa T; Ota S; Ibata M; Shono Y; Mashiko S; Miura Y; Umehara S; Kahata K; Toyoshima N; Morioka M; Asaka M; Kasai M; Imamura M
Am J Hematol; 2005 Jan; 78(1):67-70. PubMed ID: 15609290
[TBL] [Abstract][Full Text] [Related]
60. A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene.
Saba N; Safah H
Blood; 2013 Aug; 122(6):861. PubMed ID: 24079014
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
